Home/Filings/4/0001209191-19-060092
4//SEC Filing

Tokman Alexander Y 4

Accession 0001209191-19-060092

CIK 0001681682other

Filed

Dec 10, 7:00 PM ET

Accepted

Dec 11, 5:53 PM ET

Size

5.4 KB

Accession

0001209191-19-060092

Insider Transaction Report

Form 4
Period: 2019-12-11
Tokman Alexander Y
DirectorChief Executive Officer
Transactions
  • Award

    Stock option (right to buy)

    2019-12-11+89,58589,585 total
    Exercise: $0.90Exp: 2029-12-11Common Stock (89,585 underlying)
Footnotes (1)
  • [F1]These options vest and become exercisable in three equal annual installments beginning on the one year anniversary of the grant date.

Issuer

ENDRA Life Sciences Inc.

CIK 0001681682

Entity typeother

Related Parties

1
  • filerCIK 0001334483

Filing Metadata

Form type
4
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 5:53 PM ET
Size
5.4 KB